A Phase 1, Open-Label Pharmacokinetic Study to Investigate Drug Penetration in the Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Afabicin (Primary)
- Indications Bone and joint infections; Staphylococcal infections
- Focus Pharmacokinetics
- Sponsors Debiopharm
- 24 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Jul 2017.
- 24 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jul 2017.
- 15 Jun 2017 Planned number of patients changed from 16 to 17.